A series of TRPA1 antagonists is described having a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine or a 1-aryloxyisoquinoline scaffold. These compounds have high ligand efficiency and favorable physical properties and may thus serve as scaffolds for further optimization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2014.04.045 | DOI Listing |
Publication Analysis
Top Keywords
4-aryloxy-1h-pyrrolo[32-c]pyridine 1-aryloxyisoquinoline
8
series trpa1
8
trpa1 antagonists
8
discovery 4-aryloxy-1h-pyrrolo[32-c]pyridine
4
1-aryloxyisoquinoline series
4
antagonists series
4
antagonists described
4
described 4-aryloxy-1h-pyrrolo[32-c]pyridine
4
1-aryloxyisoquinoline scaffold
4
scaffold compounds
4
Similar Publications
Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonists.
Bioorg Med Chem Lett
July 2014
AstraZeneca, Department of Medicinal Chemistry, Montréal H4S 1Z9, Canada. Electronic address:
A series of TRPA1 antagonists is described having a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine or a 1-aryloxyisoquinoline scaffold. These compounds have high ligand efficiency and favorable physical properties and may thus serve as scaffolds for further optimization.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!